12S149: Neuropsychiatric Manifestations in Childhood Systemic Lupus Erythematosus

Saturday, November 12, 2022

5:00 PM – 6:00 PM Eastern Time

Location: Terrace Ballroom I

CE: 1

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

MT

Marinka Twilt, MD, PhD, MSc

Alberta Children's Hospital
Calgary, AB, Canada

Disclosure(s): No financial relationships with ineligible companies to disclose
EO

Ekemini Ogbu, MD, MSc

Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

Neuropsychiatric manifestations are frequently observed in childhood-onset systemic lupus erythematosus (cSLE). Identifying the pathologic process associated with its occurrence is essential to support treatment. In this session, we will focus on mood disorders and cognitive impairment, discussing diagnosis, risk factors, and neuroimaging features.

Learning Objectives:

Review the importance of mood disorders in cSLE and risk factors for its occurrence
Update on diagnosis and treatment options for cognitive impairment in cSLE
Review the neuroimaging features in cSLE and implications for neuropsychiatric pathology

Presentations:

5:00 PM – 5:15 PM Eastern Time

Mood Disorders in Childhood-Onset SLE
Speaker: Tamar Rubinstein, MD, MS – Albert Einstein College of Medicine
5:15 PM – 5:20 PM Eastern Time

Q&A
5:20 PM – 5:35 PM Eastern Time

Cognitive Impairment in Childhood-Onset SLE
Speaker: Hermine I. Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
5:35 PM – 5:40 PM Eastern Time

Q&A
5:40 PM – 5:55 PM Eastern Time

Neuroimaging in Childhood-Onset SLE
Speaker: Simone Appenzeller, MD, PhD – Unicamp
5:55 PM – 6:00 PM Eastern Time

Q&A